Pemitinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pemitinib, covering 2023-08-18 to 2023-08-18. Get the full timeline:
Most recent: Clinical Trial Update: A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant [Phase 2]